Paper Details

Paper Title

Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer.

Paper Journal Title

Nat Med

Paper Citation Count

Paper Publication Year

2018

Bio Mention

Mesh Descriptor

Author Name	Affiliation
Lacey E Dobrolecki	Baylor College of Medicine
Chad J Creighton	Dan L. Duncan Cancer Center, Baylor College of Medicine
Chad J Creighton	Baylor College of Medicine
Fabio Stossi	Baylor College of Medicine
Jeffrey W Tyner	Knight Cancer Institute, Oregon Health and Science University
Olivier Lichtarge	Baylor College of Medicine
Bing Zhang	Baylor College of Medicine
Bing Zhang	Baylor College of Medicine
Susan G Hilsenbeck	Baylor College of Medicine
Susan G Hilsenbeck	Baylor College of Medicine
Susan G Hilsenbeck	Dan L. Duncan Cancer Center, Baylor College of Medicine
Jin-Peng Sun	Shandong University School of Medicine
Charles Kent Osborne	Baylor College of Medicine
Charles Kent Osborne	Baylor College of Medicine
Charles Kent Osborne	Baylor College of Medicine
Charles Kent Osborne	Dan L. Duncan Cancer Center, Baylor College of Medicine
Mothaffar F Rimawi	Baylor College of Medicine
Matthew J Ellis	Baylor College of Medicine
Matthew J Ellis	Baylor College of Medicine
Matthew J Ellis	Baylor College of Medicine
Matthew J Ellis	Dan L. Duncan Cancer Center, Baylor College of Medicine
Michael T Lewis	Baylor College of Medicine
Michael T Lewis	Baylor College of Medicine
Michael T Lewis	Baylor College of Medicine
Michael T Lewis	Baylor College of Medicine

Column Actions